SV2005001919A - Compuestos nucleosidos para el tratamiento de infecciones virales - Google Patents
Compuestos nucleosidos para el tratamiento de infecciones viralesInfo
- Publication number
- SV2005001919A SV2005001919A SV2004001919A SV2004001919A SV2005001919A SV 2005001919 A SV2005001919 A SV 2005001919A SV 2004001919 A SV2004001919 A SV 2004001919A SV 2004001919 A SV2004001919 A SV 2004001919A SV 2005001919 A SV2005001919 A SV 2005001919A
- Authority
- SV
- El Salvador
- Prior art keywords
- treatment
- viral infections
- nucleosid
- compounds
- hepatitis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A COMPUESTOS COMPOSICIONES Y USO COMO MEDICAMENTO EN EL TRATAMIENTO DE INFECCIONES VIRALES CAUSADAS POR VIRUS DE LA FAMILIA FLAVIVIRIDAE, COMO POR EJEMPLO EL VIRUS DE LA HEPATITIS C
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51515303P | 2003-10-27 | 2003-10-27 | |
US10/861,311 US7144868B2 (en) | 2003-10-27 | 2004-06-04 | Nucleoside compounds for treating viral infections |
US10/861,090 US7202223B2 (en) | 2003-10-27 | 2004-06-04 | Nucleoside compounds for treating viral infections |
US10/861,219 US7151089B2 (en) | 2003-10-27 | 2004-06-04 | Nucleoside compounds for treating viral infections |
US60281504P | 2004-08-18 | 2004-08-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
SV2005001919A true SV2005001919A (es) | 2005-08-18 |
Family
ID=34658262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV2004001919A SV2005001919A (es) | 2003-10-27 | 2004-10-27 | Compuestos nucleosidos para el tratamiento de infecciones virales |
Country Status (10)
Country | Link |
---|---|
US (2) | US7244713B2 (es) |
EP (1) | EP1687321A1 (es) |
JP (1) | JP2007509943A (es) |
AR (1) | AR046310A1 (es) |
AU (1) | AU2004295291A1 (es) |
CA (1) | CA2543090A1 (es) |
IL (1) | IL174684A0 (es) |
NZ (1) | NZ546201A (es) |
SV (1) | SV2005001919A (es) |
WO (1) | WO2005054268A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
NZ547204A (en) | 2000-05-26 | 2008-01-31 | Idenix Cayman Ltd | Methods and compositions for treating flaviviruses and pestiviruses |
AU2003248748A1 (en) | 2002-06-28 | 2004-01-19 | Idenix (Cayman) Limited | 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
US7608600B2 (en) | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
KR20050088079A (ko) | 2002-11-15 | 2005-09-01 | 이데닉스 (케이만) 리미티드 | 2'-분지형 뉴클레오시드 및 플라비비리다에 돌연변이 |
JP2007509943A (ja) * | 2003-10-27 | 2007-04-19 | ジェネラブス テクノロジーズ インコーポレーティッド | ウイルス感染症治療のためのヌクレオシド化合物 |
TW200720285A (en) * | 2005-04-25 | 2007-06-01 | Genelabs Tech Inc | Nucleoside compounds for treating viral infections |
EP2385053B1 (en) * | 2005-11-17 | 2013-10-02 | OSI Pharmaceuticals, Inc. | Intermediates for the preparation of fused bicyclic mTOR inhibitors |
JP5254033B2 (ja) | 2005-12-23 | 2013-08-07 | イデニク プハルマセウティカルス,インコーポレイテッド | 分岐型ヌクレオシドを調製するための合成中間体の製造方法 |
EP1981890A2 (en) * | 2006-01-25 | 2008-10-22 | OSI Pharmaceuticals, Inc. | UNSATURATED mTOR INHIBITORS |
WO2008005542A2 (en) | 2006-07-07 | 2008-01-10 | Gilead Sciences, Inc., | Antiviral phosphinate compounds |
MX2010010300A (es) * | 2008-03-19 | 2010-10-26 | Osi Pharm Inc | Formas de sal de inhibidores del objetivo de rapamicina en mamiferos. |
US8809344B2 (en) | 2008-10-29 | 2014-08-19 | Apath, Llc | Compounds, compositions, and methods for control of hepatitis C viral infections |
US8853373B2 (en) * | 2009-08-14 | 2014-10-07 | Hitachi, Ltd. | Method and reagent for gene sequence analysis |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4140851A (en) | 1977-11-21 | 1979-02-20 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Synthesis and antitumor activity of 2,4,5-trisubstituted-pyrrolo2,3-d]-pyrimidine nucleosides |
JPS61229897A (ja) | 1985-04-05 | 1986-10-14 | Nippon Zoki Pharmaceut Co Ltd | 新規ヌクレオシド化合物 |
US6211158B1 (en) | 1987-04-10 | 2001-04-03 | Roche Diagnostics Gmbh | Desazapurine-nucleotide derivatives, processes for the preparation thereof, pharmaceutical compositions containing them and the use thereof for nucleic acid sequencing and as antiviral agents |
US4892865A (en) | 1987-12-01 | 1990-01-09 | The Regents Of The University Of Michigan | Pyrrolo[2,3-d]pyrimidine nucleosides as antiviral agents |
US4927830A (en) | 1988-04-08 | 1990-05-22 | The Regents Of The University Of Michigan | Acyclic pyrrolo[2,3-D]pyrimidine analogs as antiviral agents |
US4968686A (en) | 1988-04-08 | 1990-11-06 | The Regents Of The University Of Michigan | Acyclic pyrrolo [2,3-d]pyrimidine analogs as antiviral agents |
US5824796A (en) | 1988-09-28 | 1998-10-20 | Epoch Pharmaceuticals, Inc. | Cross-linking oligonucleotides |
US5763597A (en) | 1989-09-15 | 1998-06-09 | Metabasis Therapeutics, Inc. | Orally active adenosine kinase inhibitors |
AU651569B2 (en) | 1990-01-11 | 1994-07-28 | Isis Pharmaceuticals, Inc. | Compositions and methods for detecting and modulating RNA activity and gene expression |
US5681941A (en) | 1990-01-11 | 1997-10-28 | Isis Pharmaceuticals, Inc. | Substituted purines and oligonucleotide cross-linking |
JPH08506343A (ja) | 1993-02-03 | 1996-07-09 | ジェンシア・インコーポレイテッド | リキソフラノシル誘導体を含むアデノシンキナーゼ阻害物質 |
EP0695306A1 (en) | 1993-04-19 | 1996-02-07 | Gilead Sciences, Inc. | Enhanced triple-helix and double-helix formation with oligomers containing modified purines |
US5798340A (en) | 1993-09-17 | 1998-08-25 | Gilead Sciences, Inc. | Nucleotide analogs |
CA2171868A1 (en) | 1993-09-17 | 1995-03-23 | Petr Alexander | Method for dosing therapeutic compounds |
US6150510A (en) | 1995-11-06 | 2000-11-21 | Aventis Pharma Deutschland Gmbh | Modified oligonucleotides, their preparation and their use |
DE4438918A1 (de) | 1994-11-04 | 1996-05-09 | Hoechst Ag | Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung |
US6004939A (en) | 1995-07-06 | 1999-12-21 | Ctrc Research Foundation Board Of Regents | Methods for modulation and inhibition of telomerase |
US6054442A (en) | 1995-07-06 | 2000-04-25 | Board Of Regents, University Of Texas System | Methods and compositions for modulation and inhibition of telomerase in vitro |
FR2750435B1 (fr) | 1996-06-27 | 1998-08-28 | Appligene Oncor | Procede de formation de complexes d'hybridation dont la stabilite depend peu de la composition en base des deux molecules d'acides nucleiques hybridees |
US6831069B2 (en) | 1999-08-27 | 2004-12-14 | Ribapharm Inc. | Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
EP1138689A1 (en) | 2000-03-28 | 2001-10-04 | Roche Diagnostics GmbH | N8- and C8-linked purine bases as universal nucleosides used for oligonucleotide hybridization |
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
US20030008841A1 (en) | 2000-08-30 | 2003-01-09 | Rene Devos | Anti-HCV nucleoside derivatives |
MXPA03006514A (es) | 2001-01-22 | 2004-12-02 | Merck & Co Inc | Derivados de nucleosidos como inhibidores de polimerasa de acido ribonucleico viral dependiente de acido ribonucleico. |
AU2002353165A1 (en) * | 2001-12-17 | 2003-06-30 | Ribapharm Inc. | Deazapurine nucleoside libraries and compounds |
EP1458735A2 (en) | 2001-12-21 | 2004-09-22 | Micrologix Biotech, Inc. | Anti-viral 7-deaza l-nucleosides |
WO2003062256A1 (en) * | 2002-01-17 | 2003-07-31 | Ribapharm Inc. | 2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents |
CA2474563C (en) | 2002-02-13 | 2010-11-09 | Merck & Co., Inc. | Methods of inhibiting orthopoxvirus replication with nucleoside compounds |
WO2003099840A1 (en) | 2002-05-24 | 2003-12-04 | Isis Pharmaceuticals, Inc. | Oligonucleotides having modified nucleoside units |
WO2003100017A2 (en) | 2002-05-24 | 2003-12-04 | Isis Pharmaceuticals, Inc. | Oligonucleotides having modified nucleoside units |
AU2003269902A1 (en) | 2002-07-16 | 2004-02-02 | Isis Pharmaceuticals, Inc. | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
CN1671727A (zh) | 2002-07-25 | 2005-09-21 | 麦克洛基克斯生物技术有限公司 | 抗病毒7-脱氮-d-核苷及其用途 |
US7094768B2 (en) * | 2002-09-30 | 2006-08-22 | Genelabs Technologies, Inc. | Nucleoside derivatives for treating hepatitis C virus infection |
WO2004028481A2 (en) | 2002-09-30 | 2004-04-08 | Genelabs Technologies, Inc. | Nucleoside derivatives for treating hepatitis c virus infection |
CA2504554A1 (en) | 2002-11-05 | 2004-05-27 | Isis Pharmaceuticals, Inc. | 2'-substituted oligomeric compounds and compositions for use in gene modulations |
US7151089B2 (en) * | 2003-10-27 | 2006-12-19 | Genelabs Technologies, Inc. | Nucleoside compounds for treating viral infections |
US7202223B2 (en) * | 2003-10-27 | 2007-04-10 | Genelabs Technologies, Inc. | Nucleoside compounds for treating viral infections |
JP2007509943A (ja) * | 2003-10-27 | 2007-04-19 | ジェネラブス テクノロジーズ インコーポレーティッド | ウイルス感染症治療のためのヌクレオシド化合物 |
-
2004
- 2004-10-21 JP JP2006538146A patent/JP2007509943A/ja active Pending
- 2004-10-21 CA CA002543090A patent/CA2543090A1/en not_active Abandoned
- 2004-10-21 EP EP04817811A patent/EP1687321A1/en not_active Withdrawn
- 2004-10-21 AU AU2004295291A patent/AU2004295291A1/en not_active Abandoned
- 2004-10-21 NZ NZ546201A patent/NZ546201A/en not_active IP Right Cessation
- 2004-10-21 WO PCT/US2004/035271 patent/WO2005054268A1/en active Application Filing
- 2004-10-21 US US10/971,477 patent/US7244713B2/en not_active Expired - Fee Related
- 2004-10-26 AR ARP040103898A patent/AR046310A1/es unknown
- 2004-10-27 SV SV2004001919A patent/SV2005001919A/es not_active Application Discontinuation
-
2006
- 2006-03-30 IL IL174684A patent/IL174684A0/en unknown
- 2006-11-14 US US11/559,475 patent/US20070167383A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AR046310A1 (es) | 2005-11-30 |
NZ546201A (en) | 2009-05-31 |
WO2005054268A1 (en) | 2005-06-16 |
US7244713B2 (en) | 2007-07-17 |
US20050215511A1 (en) | 2005-09-29 |
EP1687321A1 (en) | 2006-08-09 |
JP2007509943A (ja) | 2007-04-19 |
AU2004295291A1 (en) | 2005-06-16 |
CA2543090A1 (en) | 2005-06-16 |
US20070167383A1 (en) | 2007-07-19 |
IL174684A0 (en) | 2006-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV2005001920A (es) | " compuestos nucleosidos para el tratamiento de infecciones virales " | |
ECSP055801A (es) | Compuestos benzofuránicos, composiciones y métodos para el tratamiento y profilaxis de infecciones virales de hepatitis c y enfermedades asociadas | |
CL2009000305A1 (es) | Compuestos derivados de 2-aril-sustituido-1-benzofurano-3-carboxamida, inhibidores de la polimerasa ns5b; composicion farmaceutica; y su uso en el tratamiento de una enfermedad causada por el virus de la hepatitis c (hcv). | |
BR112012011100A2 (pt) | compostos inibidores do vírus da hepatite, composição e uso dos mesmos | |
CL2004001161A1 (es) | Compuestos describe compuestos derivados de quinolina; composicion farmaceutica; y su uso para tratar una enfermedad causada por el virus de la hepatitis c. | |
IL195025A (en) | History of compressed indolubenzazepine with cyclopropyl and pharmaceuticals containing them as an anti-hcv drug | |
BR112013007696A2 (pt) | composto, composição farmacêutica, usos do referido composto e da referida composição | |
UY31685A (es) | Compuestos antivirales, composiciones y metodos para usarlos | |
CL2013000727A1 (es) | Compuestos derivados de nucleosidos de imidazo[1,2-f][1,2,4]triazinilo; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion por virus flaviviridae, particularmente infecciones por el virus de la hepatitis c. | |
EA200800178A1 (ru) | Ингибиторы вируса гепатита с (hcv) | |
CO6390076A2 (es) | Inhibidores de hcv ns5a | |
CO6390077A2 (es) | Inhibidores de hacv ns5a | |
CY1112848T1 (el) | Αναστολεις του ιου της ηπατιτιδας c | |
CL2009002206A1 (es) | Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales. | |
BRPI0418251C1 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
HN2006041184A (es) | Metodos y estuches para dosificar nucleosidos antivirales beta-d-2 3- didehydro-2 , 3-dideoxy 5- fluorocytidina | |
WO2007041487A3 (en) | Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family | |
CO6430431A2 (es) | Inhibidores del virus de la hepatitis c | |
CO6450600A2 (es) | Inhibidores de anillo fusionado de hepatitis c | |
CL2012001176A1 (es) | Compuestos derivados de bencimidazol-imidazol, inhibidores del virus de la hepatitis c (hcv); composición farmacéutica que los comprende; combinación farmacéutica; uso en la prevención o tratamiento de infección de hcv. | |
ECSP066959A (es) | Compuestos macrociclicos como inhibidores de la replicación viral | |
CL2012002489A1 (es) | Compuestos derivados de sililo nafto-imidazol; composición farmacéutica; y su uso para prevenir o tratar una infección por el virus de la hepatitis c. | |
BRPI1004894A8 (pt) | composto antiviral e composição farmacêutica compreendendo dito composto | |
ATE475660T1 (de) | Antivirale verbindungen | |
PA8733401A1 (es) | Compuestos de pirro[1,2-b]piridazinona |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant | ||
FD | Lapse |